Gault Cheryl Insider Trades & Stock Holdings
Gault Cheryl, Chief Operating Officer at Rapport Therapeutics, Inc. has 1 Form 4 trade on file since Sep 30, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($331.86K), net -$331.86K. Latest filing: disposed of 10K shares of $RAPP on Sep 30, 2026 at $33.19.
- Trades on file
- 1
- Open-market bought
- $0
- Open-market sold
- $331.86K
- Net open-market
- -$331.86K
- Latest filing
- Sep 30, 2026
All insider trades by Gault Cheryl
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $RAPP | Sell (Open-market sale) 10b5-1 | 10K | $33.19 | $331.86K | -8.2% | Chief Operating Officer | — |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Gault Cheryl traded
Frequently asked questions
Has Gault Cheryl been buying or selling stock?
Gault Cheryl has 0 open-market purchases and 1 open-market sale on file, net -$331.86K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Gault Cheryl's latest insider trade?
disposed of 10K shares of $RAPP on Sep 30, 2026 at $33.19.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.